Max Robotics — Global Service Robot Directory + US Certification

About

The Don Carlo Gnocchi Foundation stands as a distinguished Italian research and rehabilitation institution with a pronounced focus on the intersection of robotics, biomedical engineering, and clinical neurorehabilitation. Renowned for bridging rigorous engineering innovation with patient-centered care, the Foundation has established itself as a leading force in wearable robotics, exoskeleton technology, brain-machine interfaces, and sensor-based rehabilitation systems. The Foundation's research portfolio reflects a coherent vision: harnessing advanced robotics to restore motor function in individuals affected by stroke, multiple sclerosis, limb loss, and age-related impairments. Their landmark biomechanical dataset on human locomotion — capturing kinematics, kinetics, and EMG across diverse walking tasks in 50 healthy subjects — has become an indispensable reference for the broader robotics community, amassing nearly 180 citations. Equally influential is their work on oscillator-based gait phase estimation and real-time locomotion mode recognition, which has directly advanced the controllability of lower-limb wearable devices. Clinically, the Foundation has demonstrated meaningful outcomes through rigorous randomized controlled trials validating robot-assisted rehabilitation for hand paralysis, upper limb recovery after stroke, and gait training in the elderly using hip exoskeletons. Beyond individual devices, the Foundation contributes systematic frameworks for benchmarking wearable robots, ensuring reproducibility and translational relevance across the field. Their exploration of social robots and telerehabilitation systems further underscores a commitment to expanding accessible care. Researchers here collaborate extensively across European consortia, making the Foundation an attractive partner for interdisciplinary projects. Prospective students and collaborators will find a uniquely supportive environment where clinical insight and technological ambition converge to deliver measurable impact on human health and quality of life.